The Fenwick & West LLP practice is valued by its client base of blue-chip corporations active particularly in the life sciences and tech sectors for its ‘measured and practical approach’ to public and private M&A. The team is also very experienced at handling growth investments and regularly represents venture capital clients and portfolio/target companies in cross-border acquisitions and series investments. Bomi Lee co-heads the team from San Francisco and specialises in divestitures and carve-out transactions, while New York-based co-head Ken Myers is an expert on joint ventures and tender offers. San Francisco lawyer Douglas Cogen focuses on shareholder activism and takeover defense issues, while Santa Monica-based Kris Withrow primarily advises on transactions in the TMT sector. In New York, Ethan Skerry concentrates on private equity-backed transactions and governance matters in the life sciences and software spaces, and in Silicon Valley, David Michaels is a key contact for debt finance matters, while Stephen Fisher is highly recommended for advising on exchange offers.
Testimonials
Collated independently by Legal 500 research team.
‘The Fenwick M&A team has deep technology experience and understand my company and industry well. As a result, they are not just lawyers for a deal, but true advisors to our management team. They take a measured and practical approach, and always achieve a fantastic result to my company.’
'The Fenwick M&A team is truly exceptional from a client service and quality of service perspective. The team, across partners, counsel and associates, is highly client focused and a great partner for us. Their level of attentiveness, communication and coordination across not only one but multiple matters make them an indispensable part of our team.'
Key clients
- BILL Holdings
- Chinook Therapeutics
Work highlights
- Advised Figma, a leading web-first collaborative design platform, on its pending $20bn acquisition by Adobe.
- Advised Chinook Therapeutics, Inc. on its $3.5bn acquisition by Novartis AG.